NEUROPATHOLOGY 2027 LIMITED

🌿Early-stageactive
SC757605 · ltd · incorporated 2023-02-03
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
Why now
Window steady · low confidence
Stable recent picture — watch for any upcoming trigger event.
What changed my view
Last 30 days

No material changes in the last 30 days.

Last 90 days

No snapshot from 90 days ago — start tracking from today.

Last 180 days

No snapshot from 180 days ago — start tracking from today.

🔒Estimated value
—
Upgrade to see
Turnover
—
year to Feb 2025
Net worth
£-47.9k
book net assets
Opportunity
72/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch
What this business does
Primary activity: Other education n.e.c.
Sector: Education
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 72/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: medium (79/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
5 officers (3 active, 5 linked, 5 with DOB)
90
Ownership & PSC
1 active PSC(s) of 6 total, 6 with control declared
90
Director network
1 connected companies via shared directors
48
Filing history
22 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
72/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
77
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 102
Negative net assets
Liabilities exceed assets by £47,915
Very low cash
Cash position: £1
Net assets shrinking
Down £47,916 YoY
Cash YoY
+0%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£1
~ YoY
Net Worth
-£48k
↓ 4791600% YoY
Current Assets
£1
~ YoY
Current Liabilities
—
-£48k-£38k-£29k-£19k-£10k£1Feb 2024Feb 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-02-282024-02-28
Total assets£-47.9k£1
Current assets£1£1
Cash£1£1
Net assets£-47.9k£1

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
5
filings
  • • 4 persons-with-significant-control
  • • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (26 events)Click to expand
  1. 2026-03-05
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  2. 2026-03-04
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  3. 2026-03-04
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  4. 2026-03-04
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  5. 2025-11-26
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  6. 2025-11-13
    ➕
    FRONTZEK, Karl Joachim appointed
    director
  7. 2025-11-13
    ➕
    MARINO, Silvia appointed
    director
  8. 2025-11-13
    ➖
    GERHARDUS DU PLESSIS, Daniel, Dr resigned
    director
  9. 2025-11-13
    ➖
    LASHLEY, Tammaryn Claire, Dr resigned
    director
  10. 2025-11-13
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  11. 2025-11-13
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  12. 2025-11-13
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  13. 2025-11-13
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  14. 2025-11-13
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  15. 2025-11-13
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  16. 2024-10-23
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  17. 2023-05-05
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  18. 2023-05-05
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  19. 2023-05-05
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  20. 2023-05-05
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  21. 2023-02-06
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  22. 2023-02-03
    🏢
    Company incorporated
    As NEUROPATHOLOGY 2027 LIMITED
  23. 2023-02-03
    ➕
    SMITH, Colin, Dr appointed
    director
  24. 2023-02-03
    ➕
    GERHARDUS DU PLESSIS, Daniel, Dr appointed
    director
  25. 2023-02-03
    ➕
    LASHLEY, Tammaryn Claire, Dr appointed
    director
  26. 2023-02-03
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

58/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • +Senior director age: Director aged approximately 59 — approaching natural succession window.

Succession & seller-readiness

40/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • secondaryFounder aged 58+: Senior director is approximately 59. Early succession window.

Red flags

1 med ·
2 director resignations in last 12 months
medium

Multiple recent departures can indicate governance disagreement, succession event, or preparation for sale/stress.

Evidence: GERHARDUS DU PLESSIS, Daniel, Dr resigned 2025-11-13; LASHLEY, Tammaryn Claire, Dr resigned 2025-11-13

Shareholders & ownership

1 active beneficial owner
NameSharesVoting rightsNature of controlNotified
Mrs Silvia Marino
Individual · British · DOB 11/1967 · age 59
——sig. influencesignificant influence04/03/2026
5 historic (ceased) PSCs
  • Dr Tammaryn Claire Lashleyceased 17/11/2025· 25-50% shares · 25-50% voting
  • Dr Colin Smithceased 17/11/2025· significant influence · firm interest
  • Dr Tammaryn Claire Lashleyceased 13/11/2025· significant influence · firm interest
  • Dr Daniel Gerhardus Du Plessisceased 17/10/2025· significant influence · firm interest
  • Fm Events Consultancy Limitedceased 06/02/2023· 75-100% shares · 75-100% voting · board control

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Education & training · G postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
SOMERSET NURSERY SERVICES LTD.→
SC200542 · est 1999
£849.5k
£647.2k–£1.05M
£925.0k—290026y8478y
GENIUS PEOPLE LIMITED→
SC359992 · est 2009
£342.9k
£261.3k–£424.5k
——1317y8160y
BELMONT HOUSE LIMITED→
SC026135 · est 1948 · no financials extracted
————78y8369y
BRIDGETON COMMUNITY LEARNING CAMPUS LTD.→
SC255075 · est 2003
——£513.1k—22y8366y
CLYDESIDE INITIATIVE FOR ARTS LIMITED→
SC286669 · est 2005 · no financials extracted
————21y8366y
COSMIC COPPERS CHILDCARE LIMITED→
SC337815 · est 2008
————18y8361y
FARE SCOTLAND LTD.→
SC339537 · est 2008 · no financials extracted
————18y8375y
HEART FOR THE CITY→
SC256661 · est 2003
————22y8360y
HYDE-N-SEEK (BELLSHILL) LTD.→
SC355163 · est 2009
——£211.9k—17y8359y
KIRRIEMUIR NURSERY SCHOOL LIMITED→
SC249016 · est 2003
——£12.1k—23y8366y
ROSEMOUNT LIFELONG LEARNING→
SC190521 · est 1998 · no financials extracted
————27y8366y
THE NATIONAL PIPING CENTRE→
SC139271 · est 1992 · no financials extracted
————33y8377y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2023-02-03
Jurisdictionscotland
Primary SIC85590 — Other education n.e.c.

Registered office

60 St. Enoch Square
Level 5
Glasgow
G1 4AG
United Kingdom

Filing status

Accounts
Next due: 2026-11-30
Last made up to: 2025-02-28
Confirmation statement
Next due: 2027-02-20
Last: 2026-02-06

Officers (3 active · 2 resigned)

FRONTZEK, Karl Joachim→
director · ~42y · appointed 2025-11-13
View their other companies + combined net worth →
Active
MARINO, Silvia→
director · ~59y · appointed 2025-11-13
View their other companies + combined net worth →
Active
SMITH, Colin, Dr→
director · ~59y · appointed 2023-02-03
View their other companies + combined net worth →
Active
GERHARDUS DU PLESSIS, Daniel, Dr→
director · ~60y · appointed 2023-02-03 · resigned 2025-11-13
Resigned
LASHLEY, Tammaryn Claire, Dr→
director · ~52y · appointed 2023-02-03 · resigned 2025-11-13
Resigned

Click a director name to see their full track record across all companies.

Recent filings (22 total)

notification-of-a-person-with-significant-control
persons-with-significant-control · PSC01
2026-03-05
confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-03-05
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2026-03-04
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2026-03-04
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2026-03-04
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2025-11-26
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC01
2025-11-13
appoint-person-director-company-with-name-date
officers · AP01
2025-11-13
appoint-person-director-company-with-name-date
officers · AP01
2025-11-13
termination-director-company-with-name-termination-date
officers · TM01
2025-11-13
termination-director-company-with-name-termination-date
officers · TM01
2025-11-13
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2025-11-13
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-03-20
accounts-with-accounts-type-dormant
accounts · AA
2024-10-23
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-02-21